B-RAF mutant alleles associated with Langerhans cell histiocytosis, a granulomatous pediatric disease
about
Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester diseaseBraf mutation in interdigitating dendritic cell sarcoma: a case report and review of the literature.Langerhans cell histiocytosis in Chinese adults: absence of BRAF mutations and increased FOXP3(+) regulatory T cells.Potential clinical implications of BRAF mutations in histiocytic proliferations.Langerhans cell histiocytosis (LCH): guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 yearsMutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis.Pediatric lymphomas and histiocytic disorders of childhoodDifferentiating skin-limited and multisystem Langerhans cell histiocytosis.Automated universal BRAF state detection within the activation segment in skin metastases by pyrosequencing-based assay U-BRAF(V600)BRAF gene: From human cancers to developmental syndromes.How I treat Langerhans cell histiocytosis.Clinicopathological features and BRAFV600E mutations in patients with isolated hypothalamic-pituitary Langerhans cell histiocytosis.Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages.Progress in understanding the pathogenesis of Langerhans cell histiocytosis: back to Histiocytosis X?Frequent BRAF (V600E) mutation has no effect on tumor invasiveness in patients with Langerhans cell histiocytosis.BRAF Mutation Correlates With High-Risk Langerhans Cell Histiocytosis and Increased Resistance to First-Line Therapy.The presence of CXCR4+ CD1a+ cells at onset of Langerhans cell histiocytosis is associated with a less favorable outcomeBRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups.Pathological consequence of misguided dendritic cell differentiation in histiocytic diseases.Targeting BCL2 family in human myeloid dendritic cells: a challenge to cure diseases with chronic inflammations associated with bone loss.Protein-protein interaction networks studies and importance of 3D structure knowledge.Updates on histiocytic disorders.Personalized medicine in hematology - A landmark from bench to bedLangerhans-cell histiocytosis (LCH) a presentation of two siblings with two different entities.A somatic mutation in erythro-myeloid progenitors causes neurodegenerative disease.Histiocytic neoplasms in the era of personalized genomic medicine.Langerhans cell histiocytosis is a neoplasm and consequently its recurrence is a relapse: In memory of Bob Arceci.Erdheim-Chester disease (ECD): Case report, clinical and basic investigations, and review of literature.BRAFV600E-mutation is invariably present and associated to oncogene-induced senescence in Erdheim-Chester disease.Prospective blinded study of BRAFV600E mutation detection in cell-free DNA of patients with systemic histiocytic disorders.Assessment of BRAF(V600E) mutation in pulmonary Langerhans cell histiocytosis in tissue biopsies and bronchoalveolar lavages by droplet digital polymerase chain reaction.Swelling of bilateral parotid glands: An unusual symptom of multisystem Langerhans cell histiocytosis.Anatomy of protein disorder, flexibility and disease-related mutationsGenetic homogeneity of adult Langerhans cell histiocytosis lesions: Insights from BRAFV600E mutations in adult populations.BRAFV600E mutation in cutaneous lesions of patients with adult Langerhans cell histiocytosis.Hematopoietic origin of Langerhans cell histiocytosis and Erdheim-Chester disease in adults.A phase IIa study of afuresertib, an oral pan-AKT inhibitor, in patients with Langerhans cell histiocytosis.Cutaneous Langerhans cell histiocytosis : The spectrum of a rare cutaneous neoplasia.Type II RAF inhibitor causes superior ERK pathway suppression compared to type I RAF inhibitor in cells expressing different BRAF mutant types recurrently found in lung cancer.Langerhans cell histiocytosis associated with lymphoma: an incidental finding that is not associated with BRAF or MAP2K1 mutations.
P2860
Q28240576-6B3BF6D1-9370-4789-ACBD-FE575F0190E2Q30966783-84251AB4-BA72-456D-B17F-6D85529D57F6Q33898486-F63337CB-2AB2-4446-A2EA-A95BBA8C9972Q34100859-811DAD9D-2E00-490C-8974-30167FCACBE0Q34308876-C736FF53-BFC3-4788-9503-AF5575EF168DQ34471813-F26E39F9-4119-432E-AACD-1B41D1534BFEQ34605894-BCF2B5D8-4ECE-4B07-A823-2528220AA5E4Q34624753-42172E16-57A8-4157-8264-79EE6265AAAAQ34650871-008E160B-0F5D-4D5B-AEA8-8E016E140E13Q35802430-DCE4DB2A-758E-4AE9-B6E3-5F50E76B1259Q35820361-D9C210FF-4A52-4333-95D8-03299445E265Q37350433-E06FFB0D-0083-4072-9C89-31F9211A2E9EQ37509422-8F8C3773-86B1-4983-A676-987EFFDBD71EQ37540499-A9035FFF-88A3-49AA-B322-127C565CDE0EQ37565630-B0E61A3C-21F8-47D4-BC80-83D95E825396Q37659076-DE6AA022-B7C6-48E5-8457-38648B7327CFQ37662002-8A18F0C9-1942-4F6B-8EF0-5676AB797B04Q37689383-E40AE56F-EC6B-4D4D-9F12-32B177EC6037Q37700809-0BB86ABB-FB64-444B-B8BA-F4355788D647Q38114069-FD3DEE52-852C-4DD8-A689-4E58BF69FDABQ38160928-05E1D6C5-E4F2-4EE1-B20C-E8C5904F93BBQ38194538-9E6259BB-4312-4AFC-9B1E-7A4171A30039Q38263199-486A6C3E-7589-4F7F-AFE5-15441A289402Q38550587-525F18D4-9355-43C4-814F-E7CCC76A1A5FQ38602233-A347C4EC-68E8-4703-8646-15A23F95B77FQ38814135-C4070000-ADEC-4C0F-8D8C-530D58898520Q38868299-B1998067-91F3-475C-81D9-7BB365249610Q38985335-B7E953A7-6D1A-4739-AD47-F32C9C317877Q40180256-BCEFA75F-8844-4FCE-87B8-D6C60C1C1180Q40229747-4A914760-BC01-480A-B71B-E28705726816Q40486824-E4C44ABF-9464-4F32-97C1-699329ACB9C9Q41028022-ACC47655-08E2-4A5F-9D08-1BE490B15AB9Q41919553-31137A67-E400-48D0-96FB-E29C5AE40F0AQ44195415-76AC01EE-73F0-412C-9339-443033EF4E34Q46779278-9445A64C-FD53-4AF2-B9F4-8F1EA1047409Q49568680-DCF9EEFF-698A-4913-9D5F-DB9799CB26EEQ51349854-129B41B5-348E-4143-8537-C2693905DF76Q53066678-11192CDC-2703-42D7-8DB4-FBC5CE6FF2B8Q54115748-416702E4-65ED-4D19-8F30-E93B6C056830Q54154488-D147EEFC-3A11-49BE-BA46-912357E9EC66
P2860
B-RAF mutant alleles associated with Langerhans cell histiocytosis, a granulomatous pediatric disease
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
B-RAF mutant alleles associate ...... ranulomatous pediatric disease
@ast
B-RAF mutant alleles associate ...... ranulomatous pediatric disease
@en
B-RAF mutant alleles associate ...... ranulomatous pediatric disease
@en-gb
B-RAF mutant alleles associate ...... ranulomatous pediatric disease
@nl
type
label
B-RAF mutant alleles associate ...... ranulomatous pediatric disease
@ast
B-RAF mutant alleles associate ...... ranulomatous pediatric disease
@en
B-RAF mutant alleles associate ...... ranulomatous pediatric disease
@en-gb
B-RAF mutant alleles associate ...... ranulomatous pediatric disease
@nl
altLabel
B-RAF Mutant Alleles Associate ...... ranulomatous Pediatric Disease
@en
prefLabel
B-RAF mutant alleles associate ...... ranulomatous pediatric disease
@ast
B-RAF mutant alleles associate ...... ranulomatous pediatric disease
@en
B-RAF mutant alleles associate ...... ranulomatous pediatric disease
@en-gb
B-RAF mutant alleles associate ...... ranulomatous pediatric disease
@nl
P2093
P2860
P50
P3181
P1433
P1476
B-RAF mutant alleles associate ...... ranulomatous pediatric disease
@en
P2093
Alexander Smith
Aurelien Sarde
Celine Trouillet
Ghulam Mufti
Hui-chun Lu
Jean Donadieu
Jean-Francois Emile
Sophie Mian
Takeshi Satoh
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0033891
P407
P577
2012-01-01T00:00:00Z